Vaccine development with emphasis on vector vaccines based on Modified Vaccinia virus Ankara (MVA). Prevention of zoonotic and emerging virus infections, e.g. avian influenza, MERS, SARS, West Nile fever, orthopoxvirus infections. Mechanisms of (pox-) viral modulation of the host immune system including evasion of innate and adaptive responses to infection.